Israel - English - Ministry of Health

teva israel ltd - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor teva, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event . limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor s.k., co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event.limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor s.k., co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event.limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

propharm ltd - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor propharm is indicated for co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

propharm ltd - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor propharm is indicated for co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

novartis israel ltd - ticagrelor - film coated tablets - ticagrelor 90 mg - ticagrelor - ticagrelor sandoz®, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event.limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Israel - English - Ministry of Health

novartis israel ltd - ticagrelor - film coated tablets - ticagrelor 60 mg - ticagrelor - ticagrelor sandoz®, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with - acute coronary syndromes (acs) or- a history of myocardial infarction (mi) and a high risk of developing an atherothrombotic event.limitations of use: 90 mg twice daily during the first year after an acs event followed by 60 mg twice daily for additional 2 years.

Canada - English - Health Canada

taro pharmaceuticals inc - ticagrelor - tablet - 60mg - ticagrelor 60mg - platelet aggregation inhibitors

Canada - English - Health Canada

taro pharmaceuticals inc - ticagrelor - tablet - 90mg - ticagrelor 90mg - platelet aggregation inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - ticagrelor - film-coated tablet - ticagrelor